| Literature DB >> 31817041 |
Kankadeb Mishra1,2, Chandrasekhar Kanduri1.
Abstract
With the evolution of technologies that deal with global detection of RNAs to probing of lncRNA-chromatin interactions and lncRNA-chromatin structure regulation, we have been updated with a comprehensive repertoire of chromatin interacting lncRNAs, their genome-wide chromatin binding regions and mode of action. Evidence from these new technologies emphasize that chromatin targeting of lncRNAs is a prominent mechanism and that these chromatin targeted lncRNAs exert their functionality by fine tuning chromatin architecture resulting in an altered transcriptional readout. Currently, there are no unifying principles that define chromatin association of lncRNAs, however, evidence from a few chromatin-associated lncRNAs show presence of a short common sequence for chromatin targeting. In this article, we review how technological advancements contributed in characterizing chromatin associated lncRNAs, and discuss the potential mechanisms by which chromatin associated lncRNAs execute their functions.Entities:
Keywords: RNA-chromatin interactions; chromatin; chromatin RNA; gene regulation; lncrna; long noncoding RNA
Year: 2019 PMID: 31817041 PMCID: PMC6958424 DOI: 10.3390/ncrna5040054
Source DB: PubMed Journal: Noncoding RNA ISSN: 2311-553X
Histone modifications, chromatin and DNA modifiers in characterizing chromatin associated lncRNAs: Examples of well characterized chromatin enriched lncRNAs and the techniques used to validate their detection as well as functional interaction with particular proteins.
| Long Noncoding RNA | Function | Site of Action | Technique/Approach | Interacting Proteins | Ref. |
|---|---|---|---|---|---|
|
| |||||
|
| Lineage-specific transcriptional silencing at the imprinted | G9a, PRC2, DNMT1 (lineage specific interaction) | [ | ||
|
| Lineage specific transcriptional silencing of imprinted genes | [ | |||
|
| Transcriptional silencing of |
| PRC2 (EZH2) | [ | |
|
| Homeotic gene activation at |
| WDR5 | [ | |
|
| Activation of cardiovascular progenitor |
| PRC2(SUZ12) | [ | |
|
| Differentiation of tissues derived from lateral mesoderm |
| EZH2, SUZ12 (PRC2), WDR5 (simultaneous interaction) | [ | |
|
| Controlling cellular senescence by transcriptional silencing | CBX7 (PRC1) | [ | ||
|
| Epigenetic regulation via p53 response |
| PRC2 | [ | |
|
| Epigenetic regulator of cardiac hypertrophy |
| EZH2 (PRC2) | [ | |
|
| Regulation of CpG methylation at the rRNA genes |
| DNMT3b recruited to DNA: RNA triplex at target promoter | [ | |
Figure 1Timeline of technological advances to study RNA-Protein and RNA-Chromatin interactions. Upper panel (light sea-green box) depicts in chronological order the prominent methods (in blue) to detect RNA interactions with chromatin. Examples of some of the functionally validated lncRNAs from each of these studies are shown (in black) below the corresponding method. Middle panel depicts the year in which these methodologies were published. Lower panel (light pink box) likewise shows in chronological order methods (in green) to identify RNA interactions with proteins.
Comparison of chromatin-associated RNA profiling methodologies: Data-based comparative analysis for the ability of these techniques to detect expression independent chromatin targeting of lncRNAs.
| ChRIP-seq | PIRCh-seq | GRID-seq | MARGI-seq | ChAR-seq | ||
|---|---|---|---|---|---|---|
| Active XH lncCARs | Inactive lncCARs | |||||
| Cell lines used | BT-549 | BT-549 | H9, HFF, mESC, MEF and mNPC | MBA-MB-231, mESC, S2 | hESC, HEK | CME-W1-cl8+ |
| Organism | Human | Human | Human and Mouse | Human, Mouse and | Human |
|
| Number of cells/chromatin required | 50–60 µg chromatin per IP | 50–60 µg chromatin per IP | 10–20 µg chromatin per IP | 5–10 µg chromatin per library | 10,000–20,000 µg chromatin per library | 100–400 million |
| Crosslinking | 1% Formaldehyde | UV and 1% Formaldehyde | 1% Glutaraldehyde | Formaldehyde and DSG | 1% Formaldehyde | 1% Formaldehyde |
| Probes or oligos | Antibody based | Antibody based | Antibody based | Customized biotinylated bivalent linker | Ligation based: customized linker DNA. | Biotinylated oligonucleotide bridge (linker DNA) |
| Technical limitations | Chromatin fragment size | Chromatin fragment size | Chromatin fragment size | Frequency of AluI restriction sites in the genome | Specificity of linker ligation to RNA and the proximity of bound RNA to free DNA ends (fragment size) | Specificity of bridge ligation to RNA and the proximity of bound RNAs to free DNA ends (fragment size) |
| Number of chromatin bound ncRNAs | 209 | 276 | 258 | 72 (7.36%) | Not provided | Less ncRNA and abundant mRNAs |
| Overrepresented class of ncRNAs | 191 lncRNAs out of 209 ncRNAs | lncRNAs and novel transcripts (“cuffs”) | 247 lncRNAs out of 258 ncRNAs | 32 lncRNAs | Not provided | 18% snoRNA |
| Relation with steady state levels of nuclear expression | Chromatin enrichment of active lncCARs independent of steady state nuclear levels | Information not provided | lncRNAs overrepresented as compared to mRNAs or other ncRNAs that generally has higher expression. | Positively correlated | Positively correlated | Positively correlated |
| Nascent transcript enrichment | Actinomycin D treated cells were used for the assay. Functionally characterized active XH lncCARs were validated for transcription independent chromatin enrichment | Not mentioned | Less compared to GRID-seq [ | Nascent transcripts are enriched | In HEK cell pxRNA peaks detected in 69.1% of all the transcription start sites. DiRNA peaks detected in 61% of all the transcription start sites | Yes. Positive correlation with (Permissive nuclear Run-On sequencing) PRO-seq data [ |
| Mechanism of action | Active XH lncCARs regulate transcription | One of the inactive CARs | Validated chromatin targeting of | No | No | No |
| References | [ | [ | [ | [ | [ | [ |
Figure 2Mechanisms of chromatin targeting of lncRNAs.Three broad mechanisms that explain both cis and trans acting lncRNAs targeting to the chromatin. (A–E) depicts possible mechanisms by which lncRNAs associate with chromatin through interacting with chromatin modifiers, chromatin readers and/or RNA binding proteins. LncRNAs that interact with proteins with dual RNA-DNA binding properties can bind to chromatin enriched with active (A) or inactive histone modifications (E), or interacts with RNA binding subunit of a heterocomplex chromatin modifiers (B), or lncRNAs can directly be targeted (triplex or R-loop) to chromatin as a complex with any RBP (C) or histone modification readers can recruit RBP bound lncRNAs that can subsequently interact with chromatin via histone modifications (D). Inactive chromatin associated lncRNAs (iCARs) can be recruited to chromatin by a single (E) or heterocomplex chromatin modifiers (not shown) with histone reading as well as modifying functions and such recruitments leads to spreading of inactive chromatin through repressive histone marks. (F–G) Triplex and R-loop forming lncRNAs can target chromatin in cis vs. trans (F–I). There might be a same (F) or different (G) group of protein complexes that might play a role in either stabilizing triplex formation by cis (F) or trans-acting (G) lncRNAs via binding to triplex forming oligos (TFOs). Similarly, R-loop formation might be coordinated by different protein complexes in cis (H) as compared to (if any) in-trans targeting (I).
Mechanism of chromatin targeting of lncRNAs: Examples of diverse chromatin enriched lncRNAs that target chromatin via proteins with dual DNA-RNA binding properties, by triplex structure or R-loop formation. Techniques used to validate their chromatin interaction property and also their mode (triplex and R-loops) of targeting to chromatin.
| Long Noncod RNA | Function | Site of Action | Technique/Approach | Interacting Protein | Ref. |
|---|---|---|---|---|---|
|
| |||||
|
| YY1-mediated regulation of myogenesis | 386–851 bp region of the | [ | ||
|
|
| hnRNPA2/B1 and SOX2 | [ | ||
|
| Notch regulated enhancing of IGF1 signaling | Interacts with IGF1R intronic enhancer to recruit Mediator and RNAP2 | [ | ||
|
| Transcriptional repressor in p53-dependent response |
| hnRNP-K: 780 nt region at the 5′ end of lincRNA-p21interacts with hnRNPK1 | [ | |
|
| Regulation of mitochondrial homeostasis and metabolism |
| p32 | [ | |
|
| |||||
|
| X chromosome inactivation |
| EZH2 (PRC2) SHARP, SAF-A and LBR. hnRNPK binds to a 600 nt region of | [ | |
|
| Role in adipogenesis; by mediating inter-chromosomal interactions | Interacts with hnRNPU through a 156-bp repeat RNA domain | [ | ||
|
| Nucleation and maintenance of paraspeckles |
| Paraspeckle proteins | [ | |
|
| Splicing, CeRNA |
| SRSF1 to regulate splicing of mRNAs | [ | |
|
| |||||
|
| Tumor suppressor lncRNA, Transcriptional repression of TGF-β pathway genes via triplex formation |
| EZH2(PRC2) | [ | |
|
| Transcriptional activation of |
| p300/CBP | [ | |
|
| Regulates seed dormancy and flowering time through the regulation of FLC expression and flowering |
| AtNDX binds to | [ | |
|
| Promote transcriptional activation of the |
| Interacts with single stranded DNA(R-loop) to enhance NF-κB binding at the VIM1 promoter | [ | |
|
| Maintenance of short telomeric structure by regulating the rate of replicative senescence | Interacts with telomeric DNA forming R-loops that promotes homology directed repair at very short telomeres by excluding Rif2 mediated RNase H2 recruitment | [ | ||
Figure 3Mechanism of in-cis chromatin targeting. Proposed model elucidating three different mechanisms of in-cis chromatin targeting of some of the well characterized lncRNAs. (A) Xist lncRNA upon transcription from the X-chromosome (red bar depicts the promoter) that is due to be inactivated, interacts with YY1 protein. YY1, being bifunctional RNA-DNA interacting protein, binds to YY1 binding sites (green bar) downstream of Xist promoter thereby retaining the newly transcribed Xist in cis. hnRNPU is another bifunctional protein, which can interact with both chromatin and RNA, binds at the 5′ end of Xist and targets it to chromatin. Nucleated Xist lncRNA then spreads along the entire X-chromosome using the three-dimensional folding of the chromatin with the aid of other transcriptional repressor complexes such as SHARP and PRC2. (B) Kcnq1ot1 lncRNA is exclusively transcribed (arrows depicting transcription) from an unmethylated paternal ICR (imprinted control region) (sky blue box), located within the intron 10 of its sense partner gene Kcnq1 gene. It functions in-cis to repress (blunted arrows represent transcriptional repression) lineage specific imprinted genes. Kcnq1ot1 (light green) interacts with and recruits G9a-PRC1-PRC2 complex to the promoters of placental linage genes (Blue boxes), while it additionally interacts with DNMT1 and targets G9a-PRC1-PRC2/DNMT1 complex to the promoters of genes that are silenced in all tissues in lineage independent fashion (Red boxes). The targeting and spreading to specific promoters across 1 mega-base region, unlike the whole X-chromosome spreading by Xist, is mediated by the three-dimensional folding of the chromatin. (C) Active XH lncCARs exemplify the case of in-cis targeting of lncRNAs to specific promoter regions of neighbouring protein coding genes to maintain their transcriptional activation. In the model, either the XH lncCARs first binds to WDR5-methyl transferase complex through the RNA binding pocket of WDR5 and then targeted (dashed black arrows) to chromatin at H3K4me2 (WDR5 reads H3K4me2), or they can directly bind H3K4me2 enriched chromatin (dashed red arrows) and act as a scaffold for the efficient docking of WDR5-methyl transferase complex which is necessary to maintain H3K4me2 levels and catalyse the conversion of H3K4me2 to H3K4me3. The maintenance of H3K4me2 marks is possibly mediated by a different WDR5- methyl transferase complex that is independent of the role of XH lncCARs.